Publications and conferences
• Boharoon H, Tomlinson J, Limback-Stanic C, Gontsorova A, Martin N, Hatfield E, Meeran K, Nair R, Mendoza N, Levy J, McAdoo S, Pusey C, Wernig F. A Case series of Patients with Isolated IgG4- related Hypophysitis treated with Rituximab. Journal of the Endocrine Society. Accepted Maunscript, published 21 April 2020• Clarke S, Abbara A, Brewster R, Simmonard A, Eng PC, Phylactou M, Papadopoulou D, Izzi- Engbeaya D, Sam A, Wernig F, Jonauskyte E, Comninos A, Meeran K, Kelsey T, Dhillo W. CasePharacodynamic response to anti-thyroid drugs in Graves’ hyperthyroidism. Frontiers in Endocrinology. 12 May 2020.
• Marques P, Caimari F, Hernandez-Ramirez LC, Collier D, Iacovazzo D, Ronaldson A, Magdid K, Lim CT, Stals K, Ellard S, Grossman AB, Korbonits M; FIPA Consortium: Significant Benefits of AIP Testing and Clinical Screening in Familial Isolated and Young-Onset Pituitary Tumors. J Clin Endocrinol Metab. Jun 2020; 105(6)• Zaman S, Patel B, Glynne P, Vanderpump M, Alsafi A, Khan S, Flora R Palazzo F, Wernig F: A rare cause of severe Cushing’s syndrome. Endocrinol Diabetes Metab Case Rep. Mar 13, 2020• Marques P, Stelmachowska-Banas M, Collier D, Wernig F, Korbonits M: Pachydermoperiostosis mimicking the acral abnormalities of acromegaly. Endocrine. Feb 2020; 67(2):499-500.• Sharma R, Wang WM, Yusuf S Evans J, Ramaswami R, Wernig F, Frilling A, Mauri F, Al-Nahhas A, Aboagye EO, Barwick TD: 68Ga-D”OTATATE PET/CT parameters predict response to peptide receptor radionuclide therapy in neuroendocrine tumours. Radiother Oncol. Dec 2019; 141:108-115• Poo SX, Tham CSW, Smit C, Lee J, Cairns T, Galliford J, Hamdulay S, Jacyna M, Levy JB, McAdoo SP, Roufosse C, Wernig F, Mason JC, Pusey CD, Tam FWK, Tomlinson JAP: IgG4-related disease in a multi-ethnic community:clinical characteristics and association with malignancy. QJM. Oct 2019; 112(10):763-769• Pearce SHS, Dayan C, Wraith DC, Barrell K, Olive N, Jansson L, Walker-Smit T, Carnegie C, Martin KF, Boelaert K, Gilbert J, Higham CE, Muller I, Murray RD, Perros P, Razvi S, Vaidya B, Wernig F, Kahaly GJ: Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves’ Hyperthyroidism: A Phase I Study. Thyroid. Jun 13 (2019)• Smith C, Hameed S, Rose GE, Wernig F: A 61 year old man with pancreatitis, pituitary dysfunction, and painful exophthalmos. BMJ, Feb 21 (2019)• Abbara A, Clarke S, Eng PC, Milburn J, Joshi D, Comninos AN, Ramli R, Mehta A, Jones B, Wernig F, Nair R, Mendoza N, Sam AH, Hatfield E, Meeran K, Dhillo WS, Martin NM: Clinical and biochemical characteristics of patients presenting with pituitary apoplexy. Endocr Connect. Aug 23 (2018), pii 18-0255.• Maher M, Roncaroli F, Mendoza N, Meeran K, Canham N, Kosicka-Slawinska M, Bernhard B, Collier D, Drummond J, Skordilis K, Tufton N, Gontsarova A, Martin N, Korbonits M, Wernig F: A patient with a germline SDHB mutation presenting with an isolated pituitary macroprolactinoma. Endocrinol Diabetes Metab Case Rep. Jul 21 (2018), pii 18-0078.• Wernig F, Jayasena C, Dhillo, WS: Carcinoid syndrome and neuroendocrine tumours. Endocrine Cancer. Medicine 45:9 (2017),543-546
...
Patient reviews
P. Verified Patient
07/06/2022
Would you recommend this doctor?
Patients comments
Very professional and knowledgeable. Dr Wernig took his time to listen to my symptoms and gave me many options to consider. He also has a very holistic approach to treatment. I would definitely recommend him to friends and family.
P C. Verified Patient
07/06/2022
Would you recommend this doctor?
Patients comments
Dr Wernig filled me with full confidence and indeed four weeks on the recommended surgery has been completed to full satisfaction.
D M. Verified Patient
07/06/2022
Would you recommend this doctor?
Patients comments
I was seen very quickly by Dr Wernig, who gave a very clear explanation of the problem and the proposed solution. It was a very satisfying consultation.
C G. Verified Patient
07/06/2022
Would you recommend this doctor?
Patients comments
Dr Wernig was very professional whilst at the same time warm and compassionate. He is a good communicator and took the time to listen as well as inform. I left my consultation feeling as though I’d been heard and with a clearer idea of the path forward.